Speaking of FoB collaborations…there’s a new one between India’s Strides and Pfenex (a private US company) to develop a Betaseron FoB: http://www.pharmatimes.com/Article/13-04-17/Cipla_launches_Enbrel_biosimilar_in_India.aspx